CompletedNot Applicable

Tele Nursing Application For Type 1 Diabetes Mellitus Adolescents

Turkey (Türkiye)67 participantsStarted 2021-12-20

Plain-language summary

Studies have shown that tele-nursing practice is effective in children with Type 1 Diabetes Mellitus, but the number of studies conducted is very few. No study examining the concepts of metabolic control, self-efficacy, quality of life and anxiety together was found in the literature review. With this study, it is aimed that diabetes education given by tele-nursing has an effect on metabolic control, self-efficacy, quality of life and anxiety level of adolescents with type 1 diabetes, and that diabetic adolescents can easily obtain the information they need about nursing care when they cannot come to the clinic.

Who can participate

Age range

12 Years – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Inclusion Criteria: * The child is between the ages of 12-18, * After the information, the adolescent agrees to participate in the study, and the parent gives written consent, * The child can understand and speak Turkish, * Parent's ability to understand and speak Turkish, * Having a smart phone and having access to the internet, * Having been diagnosed with T1DM at least 1 year ago, * Being on insulin therapy by the subcutaneous route, * Coming to the outpatient clinic at least once every 3 months. Exclusion Criteria: Exclusion Criteria: * Age younger than 12 or older than 18, * Having another chronic disease, * Using an insulin pump * Having vision and hearing problems, * Using the Continuous Glucose Tracking System, * Having a physical or mental disability.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Evaluation of Metabolic control level of adolescents with type 1 diabetes

Timeframe: Baseline, 12 weeks and 24 weeks after randomization

Evaluation of the level of self-efficacy of adolescents with type 1 diabetes

Timeframe: Baseline, 12 weeks and 24 weeks after randomization

Evaluation of the level of quality of life of adolescents with type 1 diabetes

Timeframe: Baseline, 12 weeks and 24 weeks after randomization

Evaluation of the anxiety level of adolescents with type 1 diabetes

Timeframe: Baseline, 12 weeks and 24 weeks after randomization

Trial details

NCT IDNCT05211479

SponsorUniversity of Yalova

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-03-15

View on ClinicalTrials.gov More Telenursing trials